首页 | 本学科首页   官方微博 | 高级检索  
检索        

反应停治疗难治多发性骨髓瘤的临床研究
引用本文:袁朝晖,吴达军,肖希斌.反应停治疗难治多发性骨髓瘤的临床研究[J].实用临床医学(江西),2006,7(5):33-34.
作者姓名:袁朝晖  吴达军  肖希斌
作者单位:株洲市一医院 湖南株洲412000(袁朝晖,吴达军),中南大学湘雅医院 湖南长沙410000(肖希斌)
摘    要:目的:观察沙利度胺(thalidomide,反应停)治疗难治多发性骨髓瘤的疗效及副作用。方法:男性5例,女性4例,均为难治性多发性骨髓瘤,反应停治疗起始剂量为100 mg/d,根据患者耐受情况,逐渐加量,最高达400 mg/d。结果:56%(5/9)的患者对治疗有效,其中2例为完全缓解,2例部分缓解,1例进步,2例无效;患者出现不同程度的嗜睡、便秘、头晕、皮疹等副作用。结论:沙利度胺治疗难治性多发性骨髓瘤有效。

关 键 词:多发性骨髓瘤  沙利度胺  药物治疗
文章编号:1009-8194(2006)05-0033-02
收稿时间:02 20 2006 12:00AM
修稿时间:2006年2月20日

Clinical Study on Thalidomide in the Treatment of Refractory Multiple Myeloma
Yuan Zhao-hui,Wu Da-jun,Xiao Xi-bin.Clinical Study on Thalidomide in the Treatment of Refractory Multiple Myeloma[J].Practical Clinical Medicine,2006,7(5):33-34.
Authors:Yuan Zhao-hui  Wu Da-jun  Xiao Xi-bin
Institution:1. The First Hospital of Zhuzhou ,Zhuzhou 412000,China; 2. Xiangya Hospital of Centre-south University,Changsha 410000,China
Abstract:Objective:To investigate the efficacy and side effects of thalidomide in the treatment of refractory multiple myeloma.Methods:There were nine refractory multiple myeloma patients including five male and four female. Thalidomide was given to those patients at the starting dose of 100 mg/d and added the dose 100 mg/d each week until the maximum of 400 mg/d.Results:Among the 9 patients,two achieved completely remission,2 achieved partial remission,1 improved and 2 had no effect.The total response rate was 59%(5/9).The side effects were drowsiness,constipation,and debility.Conclusion:Thalidomide is effective in the treatment of refractory multiple myeloma.
Keywords:multiple myeloma  thalidomide  treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号